Healthcare provider profile · identity verified

Marilyn K. Glaser, MD

Family Practice · ALDERSON, WV · NPI 1669459616

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	422	53
Gabapentin	Gabapentin	418	63
Omeprazole	Omeprazole	409	69
Levothyroxine Sodium	Levothyroxine Sodium	304	54
Clonazepam	Clonazepam	246	33
Atorvastatin Calcium	Atorvastatin Calcium	212	40
Trazodone Hcl	Trazodone Hcl	212	35
Metoprolol Succinate	Metoprolol Succinate	207	42
Bupropion Xl	Bupropion Hcl	188	30
Metformin Hcl Er	Metformin Hcl	186	33
Tramadol Hcl	Tramadol Hcl	185	22
Montelukast Sodium	Montelukast Sodium	184	31
Pravastatin Sodium	Pravastatin Sodium	183	44
Losartan Potassium	Losartan Potassium	180	34
Alprazolam	Alprazolam	170	24
Furosemide	Furosemide	167	39
Famotidine	Famotidine	159	32
Amlodipine Besylate	Amlodipine Besylate	154	31
Albuterol Sulfate Hfa	Albuterol Sulfate	146	30
Lisinopril	Lisinopril	145	35
Prednisone	Prednisone	134	66
Eliquis	Apixaban	122	17
Pantoprazole Sodium	Pantoprazole Sodium	120	28
Azithromycin	Azithromycin	114	68
Tamsulosin Hcl	Tamsulosin Hcl	114	24
Lorazepam	Lorazepam	111	16
Citalopram Hbr	Citalopram Hydrobromide	109	24
Rosuvastatin Calcium	Rosuvastatin Calcium	99	19
Hydrochlorothiazide	Hydrochlorothiazide	95	27
Duloxetine Hcl	Duloxetine Hcl	92	16
Metoprolol Tartrate	Metoprolol Tartrate	91	17
Sertraline Hcl	Sertraline Hcl	87	13
Fluconazole	Fluconazole	81	30
Fluoxetine Hcl	Fluoxetine Hcl	79	13
Clopidogrel	Clopidogrel Bisulfate	77	15
Potassium Chloride	Potassium Chloride	76	14
Simvastatin	Simvastatin	74	14
Amoxicillin	Amoxicillin	70	47
Pioglitazone Hcl	Pioglitazone Hcl	69	15
Meloxicam	Meloxicam	62	12
Spironolactone	Spironolactone	57	suppressed
Allopurinol	Allopurinol	54	suppressed
Baclofen	Baclofen	53	16
Diazepam	Diazepam	53	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	53	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	53	13
Doxycycline Hyclate	Doxycycline Hyclate	52	41
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	51	13
Oxybutynin Chloride Er	Oxybutynin Chloride	51	12
Ozempic	Semaglutide	51	suppressed
Calcitriol	Calcitriol	50	suppressed
Buspirone Hcl	Buspirone Hcl	49	suppressed
Ezetimibe	Ezetimibe	48	suppressed
Fluticasone Propionate	Fluticasone Propionate	46	suppressed
Carvedilol	Carvedilol	45	suppressed
Symbicort	Budesonide/Formoterol Fumarate	44	suppressed
Benazepril Hcl	Benazepril Hcl	43	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	42	suppressed
Cefdinir	Cefdinir	41	34
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	41	27
Tizanidine Hcl	Tizanidine Hcl	38	suppressed
Glimepiride	Glimepiride	37	suppressed
Atenolol	Atenolol	36	11
Diclofenac Sodium	Diclofenac Sodium	36	suppressed
Farxiga	Dapagliflozin Propanediol	35	suppressed
Ibuprofen	Ibuprofen	35	suppressed
Torsemide	Torsemide	35	suppressed
Topiramate	Topiramate	34	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	33	suppressed
Alendronate Sodium	Alendronate Sodium	32	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	32	suppressed
Pregabalin	Pregabalin	32	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	31	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	30	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	30	suppressed
Tradjenta	Linagliptin	30	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	29	suppressed
Ventolin Hfa	Albuterol Sulfate	29	suppressed
Enalapril Maleate	Enalapril Maleate	27	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	suppressed
Naproxen	Naproxen	25	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	25	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	24	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	24	17
Estradiol	Estradiol	24	suppressed
Mounjaro	Tirzepatide	24	suppressed
Prazosin Hcl	Prazosin Hcl	24	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Glipizide Er	Glipizide	22	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Levetiracetam	Levetiracetam	22	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	22	suppressed
Ondansetron Hcl	Ondansetron Hcl	22	suppressed
Oxycodone Hcl	Oxycodone Hcl	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	12
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	21	suppressed
Methotrexate	Methotrexate Sodium	21	suppressed
Sulindac	Sulindac	21	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	19	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	19	suppressed
Temazepam	Temazepam	19	suppressed
Glipizide	Glipizide	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Dilt-Xr	Diltiazem Hcl	17	suppressed
Entresto	Sacubitril/Valsartan	17	suppressed
Midodrine Hcl	Midodrine Hcl	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	15
Nitroglycerin	Nitroglycerin	17	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	16	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Brilinta	Ticagrelor	15	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Primidone	Primidone	15	suppressed
Sotalol	Sotalol Hcl	15	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	14	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	14	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	14	suppressed
Cephalexin	Cephalexin	13	suppressed
Humira	Adalimumab	13	suppressed
Klor-Con M20	Potassium Chloride	13	suppressed
Oxycontin	Oxycodone Hcl	13	suppressed
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Verapamil Sr	Verapamil Hcl	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Dulera	Mometasone/Formoterol	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Levofloxacin	Levofloxacin	12	suppressed
Lyrica	Pregabalin	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Ubrelvy	Ubrogepant	12	suppressed
Ibu	Ibuprofen	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed
Metformin Hcl	Metformin Hcl	11	suppressed
Potassium Citrate Er	Potassium Citrate	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error